Theralase Technologies Inc (TLT.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 83 | 77 | 49 | 55 | 104 |
| Accounts receivable | -324 | 203 | 158 | -203 | 1 |
| Other Working Capital | -1,329 | 24 | 580 | -19 | -121 |
| Other Operating Activity | -2,055 | -1,221 | -1,394 | -1,231 | -1,001 |
| Operating Cash Flow | $-3,625 | $-917 | $-607 | $-1,398 | $-1,017 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -114 | -92 | -130 | -19 | -38 |
| Purchase Sale Intangibles | N/A | N/A | 0 | -4 | -9 |
| Investing Cash Flow | $-114 | $-92 | $-130 | $-23 | $-47 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -28 | -74 | 9 | N/A | N/A |
| Debt Issued | N/A | N/A | N/A | 93 | N/A |
| Debt Repayment | -1 | -1 | -4 | -8 | -5 |
| Common Stock Issued | 0 | 2,830 | 711 | 1,115 | N/A |
| Other Financing Activity | 3,922 | 0 | 0 | 90 | 56 |
| Financing Cash Flow | $3,893 | $2,755 | $715 | $1,289 | $52 |
| Beginning Cash Position | 1,768 | 22 | 43 | 174 | 1,187 |
| End Cash Position | 1,922 | 1,768 | 22 | 43 | 174 |
| Net Cash Flow | $154 | $1,746 | $-21 | $-131 | $-1,013 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,625 | -917 | -607 | -1,398 | -1,017 |
| Capital Expenditure | -114 | -93 | -130 | -28 | -47 |
| Free Cash Flow | -3,739 | -1,010 | -737 | -1,425 | -1,065 |